Financial Review: Creative Medical Technology (NASDAQ:CELZ) & NKGen Biotech (NYSE:NKGN) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
NKGen Biotech, Inc. (NYSE:NKGN – Get Free Report)’s share price was down 3.3% during trading on Wednesday . The stock traded as low as $1.42 and last traded at $1.46. Approximately 140,934 shares traded hands during mid-day trading, a decline of 95% from the average daily volume of 2,693,942 shares. The stock had previously closed […]
SANTA ANA, Calif., April 24, 2024 NKGen Biotech, Inc. , a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK.
NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.